Ustekinumab-induced leukocytoclastic vasculitis in a young male with Crohn's disease

Dig Liver Dis. 2024 Jun;56(6):1105-1106. doi: 10.1016/j.dld.2024.02.012. Epub 2024 Mar 22.

Authors

Xiao-Peng Zhang¹, Huan Wang¹, Liang-Ru Zhu²

Affiliations

¹ Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: zhuliangru@hust.edu.cn.

PMID: 38521672
DOI: 10.1016/j.dld.2024.02.012

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Crohn Disease* / complications
Crohn Disease* / drug therapy
Humans
Male
Ustekinumab* / adverse effects
Ustekinumab* / therapeutic use
Vasculitis, Leukocytoclastic, Cutaneous* / chemically induced
Vasculitis, Leukocytoclastic, Cutaneous* / pathology

Substances

Ustekinumab

Supplementary concepts

Erythema elevatum diutinum